Featured Article
A Phase III study from The University of Texas MD Anderson Cancer Center has revealed that combining perioperative immunotherapy with chemotherapy significantly improves outcomes for patients with resectable early-stage non-small cell lung cancer (NSCLC).
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
The Impact of Biobanking and Diversity on the Success (or Failure) of Liquid Biopsy...
In this Inside Precision Medicine webinar, Dr. Courtney Noah will discuss the importance of standardized protocols for liquid biopsy collection as well as the need for greater diversity of samples in biobanks.
Can New Biomarker Data Improve Cardiovascular Risk Assessment?
A large, individual-level data analysis, has revealed that cardiovascular biomarkers were strongly associated with fatal and nonfatal cardiovascular events and mortality.
Blood Pressure Drugs More than Double Life-Threatening Bone Fracture Risk of Nursing Home Residents
An analysis of nursing home residents has revealed that blood pressure drugs more than double the risk of life-threatening bone fractures.
